NewslettersCell Therapy NewsHuman Immunology NewsMembrane Fusogenic Nanoparticle-Based HLA-Peptide-Addressing Universal T Cell Receptor-Engineered T (HAUL TCR-T) Cell Therapy in Solid TumorBy Bob - August 14, 20230250Investigators designed and evaluated the HAUL TCR-T cell therapy based on HLA-peptide loaded membrance fusogenic deliver system.[Bioengineering & Translational Medicine]Full Article